Filing Details
- Accession Number:
- 0001185185-15-003402
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2015-12-31 13:53:35
- Reporting Period:
- 2015-10-05
- Filing Date:
- 2015-12-31
- Accepted Time:
- 2015-12-31 13:53:35
- Original Submission Date:
- 2015-10-07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1530766 | Biosig Technologies Inc. | BSGM | Electromedical & Electrotherapeutic Apparatus (3845) | 264333375 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1449534 | L Kenneth Londoner | C/O Biosig Technologies, Inc. 8441 Wayzata Blvd., Suite 240 Minneapolis MN 55426 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.001 Par Value Per Share | Acquisiton | 2015-10-05 | 6,600 | $1.55 | 430,750 | No | 4 | P | Direct | |
Common Stock, $0.001 Par Value Per Share | Acquisiton | 2015-10-06 | 10,494 | $1.45 | 441,244 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- This transaction was executed in multiple trades on October 5, 2015 at prices ranging from $1.50 to $1.58. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of securities purchased at each separate price.
- This transaction was executed in multiple trades on October 6, 2015 at prices ranging from $1.39 to $1.48. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of securities purchased at each separate price.
- Pursuant to Instruction 9(b) to Form 4, this amendment amends and restates only the lines items in Table I of the original filing reporting direct purchases by the reporting person to correct the amount of securities beneficially owned following the reported transactions.